STOCK TITAN

Teladoc Health Inc Stock Price, News & Analysis

TDOC NYSE

Welcome to our dedicated page for Teladoc Health news (Ticker: TDOC), a resource for investors and traders seeking the latest updates and insights on Teladoc Health stock.

Teladoc Health (TDOC) delivers whole-person virtual care through AI-driven solutions and integrated digital health services. This news hub provides investors and healthcare professionals with essential updates on the company's strategic initiatives, operational milestones, and market developments.

Access real-time information about earnings announcements, technology partnerships, clinical research breakthroughs, and regulatory updates. Our curated collection features official press releases alongside third-party analysis of TDOC's expanding telehealth capabilities and chronic care management innovations.

Key updates include:

• Quarterly financial results
• Strategic acquisitions
• Clinical study outcomes
• Platform enhancements
• Leadership appointments

Bookmark this page for streamlined tracking of Teladoc Health's progress in transforming healthcare delivery through virtual-first solutions. Combine these updates with our comprehensive company profile for informed decision-making in the evolving digital health sector.

Rhea-AI Summary

Teladoc Health (NYSE:TDOC) reported mixed Q2 2025 results with revenue declining 2% year-over-year to $631.9 million. The company posted a net loss of $32.7 million ($0.19 per share), significantly improved from the $837.7 million loss in Q2 2024. Adjusted EBITDA decreased 23% to $69.3 million.

The Integrated Care segment showed growth with revenue up 4% to $391.5 million, while BetterHelp segment revenue declined 9% to $240.4 million. The company secured a new $300 million revolving credit facility and paid $550.6 million to retire convertible senior notes. For full-year 2025, Teladoc expects revenue between $2.501-$2.548 billion and projects continued challenges in the BetterHelp segment with revenue declining 6.8-9.2%.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.17%
Tags
-
Rhea-AI Summary

Wingspan has secured $24 million in Series B funding led by Touring Capital, bringing its total funding to $54 million. The company, which provides contractor management and payroll solutions, has demonstrated significant growth with a 200% expansion in customer base, 5x increase in average ACV, and has processed over $3 billion in payments.

The company announced Wingspan Embed, a new solution enabling HR platforms to manage contractors with features including tax automation, instant payouts, and insurance. Teladoc Health (NYSE: TDOC), a key client, uses Wingspan to manage payments for 10,000 healthcare providers, saving 28 hours monthly on payment processing.

The funding will accelerate Wingspan Embed's adoption and expand the company's presence in healthcare, insurance, staffing, and professional services sectors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.17%
Tags
none
-
Rhea-AI Summary

Teladoc Health (NYSE: TDOC), the global leader in virtual care, has scheduled its second quarter 2025 financial results announcement for Tuesday, July 29, 2025, after market close. The company will host a conference call at 4:30 p.m. ET to discuss the results.

U.S. participants can join via phone at 1-833-470-1428 using access code #606269. A live audio webcast will be available at ir.teladoc.com, with a replay accessible for approximately 90 days following the call.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.03%
Tags
Rhea-AI Summary

Teladoc Health (NYSE:TDOC) has announced the launch of Wellbound, a comprehensive employee assistance program (EAP) designed to enhance workforce wellness. The program addresses the limitations of traditional EAPs by providing a seamless, integrated experience for mental health and work-life support.

Wellbound combines BetterHelp's online therapy platform with Teladoc's existing healthcare services, offering mental health support, work-life benefits, and resources including legal consultation, financial planning, and care referrals. The program will be available to plan sponsors immediately with user access beginning in January 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.35%
Tags
none
-
Rhea-AI Summary
Teladoc Health (NYSE: TDOC), the global leader in virtual care, announced its participation in the upcoming Goldman Sachs 46th Annual Global Healthcare Conference. The company's CEO Chuck Divita and CFO Mala Murthy will present at the conference in Miami on June 11th, 2025, at 9:20 a.m. ET. Investors and interested parties can access a live audio webcast and replay of the presentation through Teladoc's investor relations website at ir.teladochealth.com.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.67%
Tags
conferences
-
Rhea-AI Summary
Teladoc Health (NYSE:TDOC) has granted restricted stock unit (RSU) awards to two new non-executive employees as employment inducement awards. The awards, effective June 1, 2025, cover a total of 80,000 shares of Teladoc's common stock. The RSUs have a vesting schedule where one-third vests after the first year, with the remaining two-thirds vesting quarterly over the following two years. These awards were approved by the company's Compensation Committee under the 2023 Employment Inducement Incentive Award Plan, complying with NYSE Rule 303A.08.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.85%
Tags
management
Rhea-AI Summary

Teladoc Health (NYSE:TDOC) has announced the issuance of inducement awards to five new employees. Four employees from the recently acquired Uplift Health Technologies received restricted stock units totaling 215,028 shares, vesting over two or three years based on continued service. Additionally, a new non-executive employee was granted 52,300 restricted stock units, with one-third vesting on the first anniversary and the remainder vesting quarterly over two years.

These awards were approved by Teladoc's Compensation Committee under the company's 2023 Employment Inducement Incentive Award Plan, complying with NYSE Rule 303A.08.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.27%
Tags
management
-
Rhea-AI Summary

Teladoc Health reported mixed Q1 2025 financial results, with revenue declining 3% year-over-year to $629.4 million. The company posted a net loss of $93.0 million ($0.53 per share), including a $59.1 million goodwill impairment charge.

The Integrated Care segment showed positive growth, with revenue up 3% to $389.5 million and improved EBITDA margin of 12.9%. However, BetterHelp segment revenue decreased 11% to $239.9 million with an EBITDA margin of 3.2%.

Key highlights include the acquisition of UpLift Health Technologies for $30 million plus potential earnout of $15 million, expanding mental health coverage to over 100 million lives. The company's outlook for 2025 projects full-year revenue between $2.47-2.58 billion and adjusted EBITDA of $263-304 million, reflecting continued challenges in the BetterHelp segment but stability in Integrated Care operations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.78%
Tags
-
Rhea-AI Summary

Teladoc Health has acquired UpLift, a virtual mental health services provider, in a $30 million all-cash deal with potential additional earnout of $15 million. UpLift, which generated approximately $15 million in revenue in 2024, brings access to over 100 million covered lives through health plan relationships and a network of 1,500+ mental health professionals.

The acquisition enables BetterHelp, Teladoc's consumer therapy division, to accept insurance benefits while expanding mental healthcare accessibility. UpLift will maintain its existing leadership under CEO Kyle Talcott and continue managing its provider network, quality oversight, and insurance administration.

This strategic move strengthens Teladoc's position in virtual mental health services, complementing its Integrated Care segment which delivered nearly one million mental health visits in 2024. The transaction closed on April 30, 2025, with UpLift's results to be included in BetterHelp's reporting segment.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.78%
Tags
Rhea-AI Summary

Teladoc Health (NYSE: TDOC), the global leader in virtual care, has scheduled its first quarter 2025 financial results announcement for Wednesday, April 30, 2025, after market close. The company will host a conference call at 4:30 p.m. ET the same day to review the results.

Participants can join via phone by dialing 1-833-470-1428 (U.S.) with access code #309585. International dial-in numbers are available through a dedicated link. A live audio webcast will be accessible at the company's investor relations website, with a replay available for approximately 90 days after the call.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.01%
Tags

FAQ

What is the current stock price of Teladoc Health (TDOC)?

The current stock price of Teladoc Health (TDOC) is $6.94 as of August 1, 2025.

What is the market cap of Teladoc Health (TDOC)?

The market cap of Teladoc Health (TDOC) is approximately 1.3B.
Teladoc Health Inc

NYSE:TDOC

TDOC Rankings

TDOC Stock Data

1.31B
173.51M
0.81%
75.9%
14.41%
Health Information Services
Services-offices & Clinics of Doctors of Medicine
Link
United States
NEW YORK